As a physician, I sometimes feel like a private investigator —piecing together clues from a patient’s story, examination and lab results. But with autoimmune diseases, the puzzle shifts. Symptoms scatter across different organs, leading patients to different specialists: a nephrologist for kidney issues, a dermatologist for rashes, a cardiologist for palpitations. Others carry vague symptoms that are easy to dismiss until you know what to look for. And often, these seemingly unrelated signs are connected.

A healthy immune system is built to protect us. It fights infections, helps wounds heal and keeps everything in balance. But when this system becomes confused, it may begin attacking the very tissues it is meant to defend. This is what we call an autoimmune disease.

In endocrinology, many conditions stem from autoimmunity — Hashimoto’s thyroiditis, Graves’ disease, Type 1 diabetes, Addison’s disease and autoimmune hypophysitis, among others. These may appear alone or arrive in clusters. Having one autoimmune condition often increases the risk of developing another.

Patients often ask what causes autoimmunity. There is rarely a single culprit; instead, it is an interplay of genetics, stress, smoking, environmental exposures, medications and infections. One infection in particular has come under renewed scientific attention: the Epstein–Barr virus (EBV).

A recent National Geographic article highlighted emerging research from Stanford University on EBV’s intriguing connection to autoimmune diseases. EBV infects about 95 percent of adults worldwide. Most of us meet this virus early in life — as a childhood fever, a teenage bout of mononucleosis, or sometimes nothing noticeable at all. And then EBV does what only a few viruses can do: it stays. It slips into our immune system’s B-cells and quietly lives there for life.

For most, EBV remains harmless. But in people with certain genetic vulnerabilities, it may act as a spark waiting for the right conditions. Recent studies show that EBV can interact with regions of our DNA that regulate immune responses — including those linked to lupus, a chronic autoimmune disease that can affect the joints, skin, kidneys, blood cells and brain. Symptoms vary widely: fatigue, joint pain, swelling, rashes, unpredictable fevers. In severe cases, lupus can cause permanent organ damage, disability, or early death.

The idea that a silent childhood virus could influence autoimmune disease years later is both unsettling and strangely comforting. Unsettling, because it reveals how early and quietly these risks can begin; comforting, because it offers a scientific explanation for something that once seemed random. And with understanding comes possibility — for prevention, earlier diagnosis and better treatment. Several EBV vaccines are already in early clinical trials, raising hope that someday we might reduce not only mononucleosis, but even the risk of autoimmune diseases it may help trigger.

In the clinic, this science has changed the way I listen. Autoimmunity does not storm into someone’s life. It whispers first. A rash that fades and returns. A blood sugar that behaves unpredictably. A menstrual cycle that suddenly shifts. A fatigue no amount of sleep can fix. I’ve met young women whose symptoms appeared one by one over months — each one looking isolated, until the pattern finally revealed itself.

Part of my role is learning to hear those whispers early: to help patients make sense of what their bodies are expressing, to reassure them that their symptoms are real, and to show them that their illness has a name, a pattern and, importantly, a path forward.

And so, I will keep listening — to the body’s early clues, to the evolving science and to the stories my patients carry. Because sometimes, catching the quietest signs makes all the difference.